These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 36573628)

  • 1. Multicenter Case-Control Study of COVID-19-Associated Mucormycosis Outbreak, India.
    Muthu V; Agarwal R; Rudramurthy SM; Thangaraju D; Shevkani MR; Patel AK; Shastri PS; Tayade A; Bhandari S; Gella V; Savio J; Madan S; Hallur VK; Maturu VN; Srinivasan A; Sethuraman N; Sibia RPS; Pujari S; Mehta R; Singhal T; Saxena P; Gupta V; Nagvekar V; Prayag P; Patel D; Xess I; Savaj P; Panda N; Rajagopal GD; Parwani RS; Patel K; Deshmukh A; Vyas A; Sistla SK; Padaki PA; Ramar D; Sarkar S; Rachagulla B; Vallandaramam P; Premachandran KP; Pawar S; Gugale P; Hosamani P; Dutt SN; Nair S; Kalpakkam H; Badhwar S; Kompella KK; Singla N; Navlakhe M; Prayag A; Singh G; Dhakecha P; Chakrabarti A
    Emerg Infect Dis; 2023 Jan; 29(1):8-19. PubMed ID: 36573628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India.
    Patel A; Agarwal R; Rudramurthy SM; Shevkani M; Xess I; Sharma R; Savio J; Sethuraman N; Madan S; Shastri P; Thangaraju D; Marak R; Tadepalli K; Savaj P; Sunavala A; Gupta N; Singhal T; Muthu V; Chakrabarti A;
    Emerg Infect Dis; 2021 Sep; 27(9):2349-2359. PubMed ID: 34087089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Could cattle dung burning have contributed to the epidemic of COVID-19-associated mucormycosis in India? Results of an experimental aero-mycological study.
    Kathirvel S; Muthu V; Rudramurthy SM; Kaur H; Chakrabarti A; Agarwal R
    Mycoses; 2022 Nov; 65(11):1024-1029. PubMed ID: 35726395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Online Registry of COVID-19-Associated Mucormycosis Cases, India, 2021.
    Arora S; Hemmige VS; Mandke C; Chansoria M; Rawat SK; Dravid A; Sethi Y; Medikeri G; Jariwala SP; Puius YA;
    Emerg Infect Dis; 2021; 27(11):2963-2965. PubMed ID: 34586056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outbreak of Mucormycosis in Coronavirus Disease Patients, Pune, India.
    Joshi S; Telang R; Tambe M; Havaldar R; Sane M; Shaikh A; Roy C; Yathati K; Sonawale S; Borkar R; Magar R; Bhitkar H; Shitole S; Nakate L; Kudrimoti J; Mave V
    Emerg Infect Dis; 2022 Jan; 28(1):1-8. PubMed ID: 34586055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of hospital environment for presence of Mucorales during COVID-19-associated mucormycosis outbreak in India - a multi-centre study.
    Biswal M; Gupta P; Kanaujia R; Kaur K; Kaur H; Vyas A; Hallur V; Behera B; Padaki P; Savio J; Nagaraj S; Chunchanur SK; Shwetha JV; Ambica R; Nagdeo N; Khuraijam R; Priyolakshmi N; Patel K; Thamke D; Dash L; Jadhav D; Bharmal R; Bhattacharya S; Rudramurthy SM; Chakrabarti A
    J Hosp Infect; 2022 Apr; 122():173-179. PubMed ID: 35124141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The emergence of post-COVID-19 mucormycosis in India: Can we prevent it?
    Gupta A; Sharma A; Chakrabarti A
    Indian J Ophthalmol; 2021 Jul; 69(7):1645-1647. PubMed ID: 34146000
    [No Abstract]   [Full Text] [Related]  

  • 8. Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World.
    Muthu V; Rudramurthy SM; Chakrabarti A; Agarwal R
    Mycopathologia; 2021 Dec; 186(6):739-754. PubMed ID: 34414555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole genome analysis of
    Michael JS; Venkatesan M; Ninan MM; Solaimalai D; Sumanth LJ; Varghese L; Kurien R; Varghese RP; C GPD
    Front Cell Infect Microbiol; 2023; 13():1251456. PubMed ID: 38029246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19-associated mixed mold infection: A case report of aspergillosis and mucormycosis and a literature review.
    Benhadid-Brahmi Y; Hamane S; Soyer B; Mebazaa A; Alanio A; Chousterman B; Bretagne S; Dellière S
    J Mycol Med; 2022 Mar; 32(1):101231. PubMed ID: 34864498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of the second wave of COVID-19 in India.
    Asrani P; Eapen MS; Hassan MI; Sohal SS
    Lancet Respir Med; 2021 Sep; 9(9):e93-e94. PubMed ID: 34216547
    [No Abstract]   [Full Text] [Related]  

  • 12. A prospective multicenter study on mucormycosis in India: Epidemiology, diagnosis, and treatment.
    Prakash H; Ghosh AK; Rudramurthy SM; Singh P; Xess I; Savio J; Pamidimukkala U; Jillwin J; Varma S; Das A; Panda NK; Singh S; Bal A; Chakrabarti A
    Med Mycol; 2019 Jun; 57(4):395-402. PubMed ID: 30085158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there an association between zinc and COVID-19-associated mucormycosis? Results of an experimental and clinical study.
    Muthu V; Kumar M; Paul RA; Zohmangaihi D; Choudhary H; Rudramurthy SM; Panda NK; Pannu AK; Sharma N; Sharma S; Chakrabarti A; Agarwal R
    Mycoses; 2021 Oct; 64(10):1291-1297. PubMed ID: 34420245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Finegoldia magna and Mucorales molds co-infection in a severe case of SARS-CoV-2 disease.
    Hristova R; Vlahova A; Christova M; Stamatov K; Stanimirov P
    J Infect Dev Ctries; 2023 Sep; 17(9):1231-1236. PubMed ID: 37824356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Part 1: Mucormycosis: prevalence, risk factors, clinical features, and diagnosis.
    Lynch JP; Fishbein MC; Abtin F; Zhanel GG
    Expert Rev Anti Infect Ther; 2023; 21(7):723-736. PubMed ID: 37262298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucormycosis: The hidden and forgotten disease.
    Darwish RM; AlMasri M; Al-Masri MM
    J Appl Microbiol; 2022 Jun; 132(6):4042-4057. PubMed ID: 35156271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Serum Iron Studies in COVID Associated Mucormycosis with Stage of the Disease.
    Rao C; R M
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronavirus disease-associated mucormycosis (CAM): A case control study during the outbreak in India.
    Wasiq M; K R; Gn A
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of environmental Mucorales contamination in and around the residence of COVID-19-associated mucormycosis patients.
    Ghosh AK; Singh R; Reddy S; Singh S; Rudramurthy SM; Kaur H; Choudhary H; Chakrabarti A
    Front Cell Infect Microbiol; 2022; 12():953750. PubMed ID: 36118044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach.
    Azhar A; Khan WH; Khan PA; Alhosaini K; Owais M; Ahmad A
    J Infect Public Health; 2022 Apr; 15(4):466-479. PubMed ID: 35216920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.